Next generations of CAR-T cells - new therapeutic opportunities in hematology?

Next generations of CAR-T cells - new therapeutic opportunities in hematology?

In recent years, the introduction of chimeric antigen receptor (CAR) T-cell therapies into clinics has been a breakthrough in treating relapsed or refractory malignancies in hematology and oncology. To date, Food and Drug Administration (FDA) has approved six CAR-T therapies for specific non-Hodgkin...

Full description

Bibliographic Details
Main Authors: Jaromir Tomasik, Marcin Jasiński, Grzegorz W. Basak
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
CAR-T cells
acute lymphoblastic leukemia
immunotherapy
lymphocyte
cytokine release syndrome
CRS
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1034707/full

Similar Items

Similar Items